Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Crexendo Q4 2025 Earnings Call - Adds ESI to Push Toward $100M After Profitable Double-Digit Organic Growth
Crexendo closed 2025 with a clean finance story, double-digit organic growth and sustained profitability, then moved quickly to buy scale. The company reported $68.2 million in revenue for the year, 1...
- Full year 2025 revenue $68.2 million, up 12% year-over-year, with Q4 revenue $18.1 million, up 11% year-over-year.
- Crexendo reported net income of $5.1 million for 2025, and non-GAAP net income of $11.4 million, continuing a string of profitable quarters, including 10 consecutive GAAP profitable quarters.
- Quarterly non-GAAP net income was $2.8 million, adjusted EBITDA for Q4 was $2.8 million or 15.3% of revenue, and adjusted EBITDA for the year was $11.2 million or 17% of revenue.
- +13 more takeaways
Rigel Pharmaceuticals Q4 2025 Earnings Call - R289 posts early 33% RBCTI in higher-dose cohorts, company profitable but GAAP gains masked by a large tax allowance release
Rigel closed 2025 with a sharp commercial inflection and a development story that matters. Net product sales hit $232 million for the year, Q4 net product sales were $65.4 million, and management guid...
- Commercial momentum: 2025 net product sales of $232 million, up $87 million or 60% versus 2024; Q4 net product sales were $65.4 million, up 41% year-over-year.
- Product mix in Q4: TAVALISSE $45.6M (up 47% YoY), GAVRETO $10.2M (up 27% YoY), REZLIDHIA $9.6M (up 29% YoY).
- Total Q4 revenue was $69.8 million, which included $4.4M of collaboration/contract revenues and product sales netted of estimated allowances of $19M.
- +12 more takeaways
NeuroPace Q4 2025 Earnings Call - RNS Growth Fuels Path to Profitability, IGE PMA Now in FDA Review
NeuroPace closed 2025 with clear commercial momentum in its core RNS business, reporting Q4 revenue of $26.6 million, full-year revenue of $100 million, and sustained RNS gross margins above 80%. Mana...
- Q4 2025 revenue $26.6M, up 24% year over year, full-year 2025 revenue $100M, up 25% versus 2024.
- RNS System revenue $22.4M in Q4, up 26% year over year, with second half 2025 RNS growth at 29%.
- Company reiterates full-year 2026 revenue guidance of $98M to $100M, assuming 20% to 22% core RNS growth, excluding any IGE contribution.
- +12 more takeaways
SoundThinking Q4 2025 Earnings Call - 15% ARR Growth Target Sets 2026 as Inflection Point Despite Revenue Timing Headwinds
SoundThinking closed 2025 with record revenue of $104.1 million, ARR of $95.4 million, and maintained double-digit adjusted EBITDA margins. Management is betting 2026 will be the inflection year, targ...
- Record full-year revenue of $104.1 million for 2025, up 2% versus 2024.
- ARR exited 2025 at $95.4 million, with management targeting approximately 15% net ARR growth in 2026, or roughly $14.6 million of ARR added, net of about $3.1 million attrition.
- GAAP revenue guidance for 2026 was lowered to $109 million to $111 million from a prior $114 million to $116 million range, due to timing delays on two expected bookings.
- +11 more takeaways
WEBTOON Entertainment Q4 2025 Earnings Call - MPU Turned Positive; Disney Partnership and 2026 Platform Launch Target
WEBTOON posted steady revenue but mixed signals. Q4 revenue was $330.7 million, down 4.1% on a constant currency basis, while full-year revenue reached $1.4 billion, up 3.9% cc. The company flagged sm...
- Q4 revenue $330.7 million, down 4.1% on a constant currency basis; full-year 2025 revenue $1.4 billion, up 3.9% cc.
- MPU returned to positive growth in Q4, up 0.7% company-wide, with Korea MPU up 3.3%; management credits AI-driven personalized recommendations.
- WEBTOON completed the strategic agreement with The Walt Disney Company on January 8, 2026, including Disney acquiring ~2.7 million shares for roughly $32.8 million, about a 2% stake.
- +12 more takeaways
Ross Stores Q4 FY2025 Earnings Call - Traffic-led 9% comp drives beat; cautious guide despite momentum
Ross closed fiscal 2025 with a clear rebound: Q4 sales rose 12% to $6.6 billion and comps accelerated to a traffic-led 9% gain, helping the company materially beat expectations. Management credits bet...
- Q4 total sales rose 12% to $6.6 billion, with comparable store sales up 9%. Management said comps were driven mainly by increased transactions and new customers, with only a modest basket increase.
- Weather shaved about 1 percentage point off Q4 comps, so the underlying momentum was broader than reported.
- Fiscal 2025 sales reached a record $22.8 billion, up 8% year over year; comparable-store sales for the year were +5%. Net income was $2.1 billion and EPS was $6.61, up from $6.32 last year.
- +12 more takeaways
Cumberland Pharmaceuticals Q4 2025 Earnings Call - Ifetroban DMD Data Pushes Drug Toward Registration, Fuels 2026 Growth Outlook
Cumberland closed 2025 with a clear message. Commercial revenue accelerated, adjusted earnings turned positive, and international moves plus new commercial brands tightened the balance sheet. The real...
- Full year 2025 revenue grew 18% to $44.5 million, with Q4 revenue of $13.7 million, up 31% year over year.
- Adjusted earnings turned positive at $1.7 million, or $0.11 per share, driven by commercial execution and acquisitions.
- Operating cash flow improved to $4.9 million for 2025, and management expects meaningful positive cash flow in 2026.
- +12 more takeaways
FRMO Corp Q2 2026 Earnings Call - Debt-free with strongest liquidity, pivot to Scrypt mining and 45% Winland stake
FRMO used proceeds from the sale of the HashMaster building to Synteq to pay its mortgage to zero and take Synteq stock, leaving the company debt-free and in its most liquid position ever. Management ...
- FRMO is now debt-free after selling the HashMaster building to Synteq, using proceeds to fully prepay the mortgage and take Synteq stock as part of consideration.
- Management says this is the most liquid balance-sheet position in FRMO history, with significant unused borrowing capacity.
- FRMO owns approximately 45 percent of publicly traded Winland, where it has been shifting new mining exposure; crossing 50 percent would trigger consolidation and change financial statement presentation.
- +11 more takeaways
Target Q1 2026 Earnings Call - $2B Incremental Investment Focused on Merchandising, Stores, and Tech to Drive Return to Growth
Target laid out a blunt, programmatic reset built around merchandising authority, an elevated in-store experience, faster technology, and a strengthened team. Management is committing a more than $2 b...
- Company frames 2026 as a new chapter anchored by four priorities: merchandising authority, elevating guest experience, accelerating technology, and strengthening team and communities.
- Target will make more than $2 billion of incremental investments in 2026, split roughly as $1 billion additional CapEx and $1 billion reinvested into the P&L.
- Full-year capital expenditures are expected to be approximately $5 billion in 2026, up more than $1 billion from 2025.
- +17 more takeaways
Netlist Q4 2025 Earnings Call - Revenue Surge Fueled by AI-driven Memory Shortage and Reinforced Patent Position
Netlist closed 2025 with a sharp operating pivot. Full-year revenue rose to $188.6 million, up 28% year over year, and Q4 revenue more than doubled versus Q4 2024 as AI-driven demand and a global DRAM...
- Full-year 2025 revenue was $188.6 million, a 28% increase year over year; Q4 2025 revenue more than doubled compared with Q4 2024.
- Management attributes 2025 strength to AI-driven memory demand and a global DRAM shortage that pushed OEM DRAM pricing roughly 3x to 4x and spot pricing 7x to 8x over six months.
- Netlist expects the memory supply shortage and elevated prices to persist through 2026 and into 2027, until new fab capacity comes online in the second half of 2027.
- +13 more takeaways